The report focuses on global major leading market players of Transdermal Patch
industry providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information.
Mechanism of Transdermal Patch
Drug Delivery - Global Transdermal Patch
Market Outlook - Transdermal Patch
Clinical Pipeline by Company, Indication & Phase - Transdermal Patches
in Clinical Pipeline: 96 - Marketed Transdermal Patches
:45 - Global Transdermal Patch
Market Future Prospects
Long-term experience with rotigotine transdermal patch
was also presented and discussed at the EFNS.
This agreement continues the validation of the Altea Therapeutics transdermal patch
technology for medicines that currently can be administered only by needle injection or infusion, including water-soluble proteins, carbohydrates, and small molecules," said Dr.
She has completed more than 10 regulatory submissions and approvals of new pharmaceutical products, including transdermal patch
and gel products.
Said Darwazah, CEO of Hikma said, We are pleased to be partnering with SK Chemicals to bring Rivastigmine transdermal patch
to patients in MENA.
NuPathe's product portfolio includes Zelrix which, if approved, would be the first and only transdermal patch
for the treatment of acute migraine, and NP201, a long acting injectable implant for the treatment of Parkinson's disease.
Our once-a-week transdermal patch
is a clearly preferable treatment method to AD patients and caregivers.
Then, as the patient takes the Applicator away from the skin, the transdermal patch
is automatically positioned on the skin to allow delivery to commence.
This agreement further validates the development of the Altea Therapeutics transdermal patch
technology for drugs that previously were administered by needle injection or infusion, including water-soluble proteins, carbohydrates, and small drugs," said Dr.
We are thrilled to welcome him as a member of our scientific advisory board and look forward to his close association with our scientists as we develop our proprietary transdermal patch
technology, the PassPort System, designed for the efficient delivery of drugs that normally would need to be administered by needle injection, including proteins, carbohydrates and water-soluble drug salts," said Dr.
ATLANTA -- Altea Therapeutics has achieved sustained and steady basal levels of insulin in patients with type 1 diabetes using a small transdermal patch
delivering recombinant human insulin in a cost-effective manner.